- Home
- STCN vs MIST Comparison
STCN vs MIST Comparison
Compare STCN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- MIST
- Stock Information
- Founded
- STCN 1986
- MIST 2003
- Country
- STCN United States
- MIST Canada
- Employees
- STCN N/A
- MIST N/A
- Industry
- STCN Advertising
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- STCN Consumer Discretionary
- MIST Health Care
- Exchange
- STCN Nasdaq
- MIST Nasdaq
- Market Cap
- STCN 63.4M
- MIST 81.5M
- IPO Year
- STCN 1994
- MIST N/A
- Fundamental
- Price
- STCN $10.40
- MIST $1.43
- Analyst Decision
- STCN
- MIST Strong Buy
- Analyst Count
- STCN 0
- MIST 3
- Target Price
- STCN N/A
- MIST $13.00
- AVG Volume (30 Days)
- STCN 11.9K
- MIST 177.8K
- Earning Date
- STCN 12-12-2024
- MIST 11-11-2024
- Dividend Yield
- STCN N/A
- MIST N/A
- EPS Growth
- STCN 203.29
- MIST N/A
- EPS
- STCN 3.17
- MIST N/A
- Revenue
- STCN $169,044,000.00
- MIST N/A
- Revenue This Year
- STCN N/A
- MIST N/A
- Revenue Next Year
- STCN N/A
- MIST N/A
- P/E Ratio
- STCN $3.19
- MIST N/A
- Revenue Growth
- STCN N/A
- MIST N/A
- 52 Week Low
- STCN $7.36
- MIST $1.12
- 52 Week High
- STCN $13.00
- MIST $3.52
- Technical
- Relative Strength Index (RSI)
- STCN 57.19
- MIST 42.50
- Support Level
- STCN $9.90
- MIST $1.41
- Resistance Level
- STCN $10.29
- MIST $1.53
- Average True Range (ATR)
- STCN 0.39
- MIST 0.07
- MACD
- STCN 0.11
- MIST -0.01
- Stochastic Oscillator
- STCN 100.00
- MIST 26.96
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).